Protein clue could predict endometrial cancer outcomes

This study will examine tissue samples from 50 people with type 1 endometrial cancer to measure levels of a protein called METTL-14. Researchers want to see if higher or lower amounts of this protein are linked to how aggressive the cancer is and how long patients live without the disease coming back. The goal is to better understand which patients might need more or less treatment, but this study does not test any new drug or therapy.